# Treating Acute Pancreatitis With Dabigatran, a Pilot Study

> **NCT03807856** · PHASE1 · TERMINATED · sponsor: **Mayo Clinic** · enrollment: 2 (actual)

## Conditions studied

- Acute Pancreatitis

## Interventions

- **DRUG:** Dabigatran Etexilate Mesylate
- **OTHER:** Standard of Care

## Key facts

- **NCT ID:** NCT03807856
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-06-24
- **Primary completion:** 2020-07-23
- **Final completion:** 2020-07-23
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Difficult recruitment
- **Last updated:** 2022-09-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03807856

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03807856, "Treating Acute Pancreatitis With Dabigatran, a Pilot Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03807856. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*